Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial

BACKGROUND: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure. Although angiotensin II receptor blockers (ARBs) can be used to attenuate proteinuria in DN patients, their efficacy remains limited. This clinical trial aimed to evaluate the efficacy of Tripterygium wilfordi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ge, Yongchun, Xie, Honglang, Li, Shijun, Jin, Bo, Hou, Jinhua, Zhang, Haitao, Shi, Mingjun, Liu, Zhihong
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3670993/
https://ncbi.nlm.nih.gov/pubmed/23725518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-134
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki